Clin2
NCT07876505Likely a fitNot yet recruiting

Comparing different forms of an experimental drug in healthy people

Healthy Volunteers

This study compares different versions of the investigational drug cenvacibart in healthy volunteers. It helps researchers understand how the drug behaves in the body when given in different forms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be in good overall health, with no major ongoing medical conditions.
  • Your weight must be between 110 and 210 pounds (50–95 kg).
  • You must not have had major surgery or a serious injury in the last 6 months.
  • You cannot have donated blood recently (whole blood in the last 56 days, plasma in the last 7 days).
  • You should not have any allergies to the study drug or its components.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07267221Recruiting· Phase 1
Comparing three versions of a drug in healthy people after a meal

This trial checks how three different versions of a medication (DWC202313, DWC202314, and DWJ1622) are absorbed by the body when taken with food. Healthy volunteers take the drugs once and have blood drawn over time to compare safety and how the drugs move through the body.

Seoul, Gwanak-gu
NCT07260851Recruiting· Phase 1
Comparing three versions of an experimental drug in healthy volunteers

This trial tests three different formulations of an experimental drug in healthy volunteers to see if they work the same way in the body. It is a first step to ensure the drug is safe before testing in patients.

Seoul, Gwanak-gu
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07797855Recruiting· Phase 1
Testing a new medicine's safety in healthy people

This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Groningen
NCT07422207Recruiting· Phase 1
Safety study of ME3241 in healthy adults

This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.

Sydney, New South Wales
NCT07635095Recruiting· Phase 1
Comparing two forms of navenibart in healthy adults

This study tests whether two different presentations (forms) of an experimental medicine called navenibart work the same way in your body. Researchers will measure how the drug moves through your system to ensure both forms are safe and effective.

Daytona Beach, Florida

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.